Loading
Latest filing published 14 Nov 2018 for Arbutus Biopharma Corporation.
No signal scores available.
Myrtle Stephens Potter is a declared insider of Arbutus Biopharma Corporation, with filings sourced from SEDI. The record holds 2 filings, all for trades on 18 October 2018.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 14 November 2018 with a transaction in Arbutus Biopharma Corporation. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations